Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. European Lung Cancer Congress 2025
  5. Satellite Symposia Webcasts

Regeneron Pharmaceuticals, Inc. - A new era: Reshaping the role of immunotherapy in the treatment of NSCLC

Leveraging the therapeutic timeline: Sequencing of ICIs and chemotherapy to derive treatment benefit after initial progression

Date

27 Mar 2025

Session

Regeneron Pharmaceuticals, Inc. - A new era: Reshaping the role of immunotherapy in the treatment of NSCLC

Presenters

Andrea Ardizzoni

Authors

A. Ardizzoni

Author affiliations

  • University of Bologna - Alma Mater Studiorum, Bologna/IT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction

Presenter: Nicolas Girard

Session: Regeneron Pharmaceuticals, Inc. - A new era: Reshaping the role of immunotherapy in the treatment of NSCLC

Resources:

Webcast

Closure

Presenter: Nicolas Girard

Session: Regeneron Pharmaceuticals, Inc. - A new era: Reshaping the role of immunotherapy in the treatment of NSCLC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.